295 related articles for article (PubMed ID: 24107629)
1. NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.
Salah Z; Cohen S; Itzhaki E; Aqeilan RI
Cell Cycle; 2013 Dec; 12(24):3817-23. PubMed ID: 24107629
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
Salah Z; Melino G; Aqeilan RI
Cancer Res; 2011 Mar; 71(5):2010-20. PubMed ID: 21212414
[TBL] [Abstract][Full Text] [Related]
3. NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway.
Bae SJ; Kim M; Kim SH; Kwon YE; Lee JH; Kim J; Chung CH; Lee WJ; Seol JH
Nat Commun; 2015 Feb; 6():6314. PubMed ID: 25692647
[TBL] [Abstract][Full Text] [Related]
4. HECT domain-containing E3 ubiquitin ligase Nedd4 interacts with and ubiquitinates Sprouty2.
Edwin F; Anderson K; Patel TB
J Biol Chem; 2010 Jan; 285(1):255-64. PubMed ID: 19864419
[TBL] [Abstract][Full Text] [Related]
5. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
Yeung B; Ho KC; Yang X
PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
[TBL] [Abstract][Full Text] [Related]
6. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Itch and Nedd4 E3 Ligase Activity and Degradation by LRAD3.
Noyes NC; Hampton B; Migliorini M; Strickland DK
Biochemistry; 2016 Mar; 55(8):1204-13. PubMed ID: 26854353
[TBL] [Abstract][Full Text] [Related]
8. Nedd4-2 phosphorylation induces serum and glucocorticoid-regulated kinase (SGK) ubiquitination and degradation.
Zhou R; Snyder PM
J Biol Chem; 2005 Feb; 280(6):4518-23. PubMed ID: 15576372
[TBL] [Abstract][Full Text] [Related]
9. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.
Lin Q; Wang J; Childress C; Sudol M; Carey DJ; Yang W
Mol Cell Biol; 2010 Mar; 30(6):1541-54. PubMed ID: 20086093
[TBL] [Abstract][Full Text] [Related]
10. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
Zou J; Zhou L; Le Y; Fang Z; Zhong M; Nie F; Wei X; Zhang X; Chen Z; Cai L; Wang H; Xiong J; Fang Z; Xiang X
Cell Commun Signal; 2023 Feb; 21(1):38. PubMed ID: 36803368
[TBL] [Abstract][Full Text] [Related]
11. p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.
Hong SW; Moon JH; Kim JS; Shin JS; Jung KA; Lee WK; Jeong SY; Hwang JJ; Lee SJ; Suh YA; Kim I; Nam KY; Han S; Kim JE; Kim KP; Hong YS; Lee JL; Lee WJ; Choi EK; Lee JS; Jin DH; Kim TW
Cell Death Differ; 2014 Jan; 21(1):146-60. PubMed ID: 24141722
[TBL] [Abstract][Full Text] [Related]
12. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].
Ho KC; Zhou Z; She YM; Chun A; Cyr TD; Yang X
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4870-5. PubMed ID: 21383157
[TBL] [Abstract][Full Text] [Related]
13. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
14. Nedd4-2 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4-2 pathway.
Arroyo JP; Lagnaz D; Ronzaud C; Vázquez N; Ko BS; Moddes L; Ruffieux-Daidié D; Hausel P; Koesters R; Yang B; Stokes JB; Hoover RS; Gamba G; Staub O
J Am Soc Nephrol; 2011 Sep; 22(9):1707-19. PubMed ID: 21852580
[TBL] [Abstract][Full Text] [Related]
15. The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation.
Wang C; An J; Zhang P; Xu C; Gao K; Wu D; Wang D; Yu H; Liu JO; Yu L
Biochem J; 2012 Jun; 444(2):279-89. PubMed ID: 22385262
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases.
Jiang H; Thomas SN; Chen Z; Chiang CY; Cole PA
J Biol Chem; 2019 Nov; 294(46):17421-17436. PubMed ID: 31578285
[TBL] [Abstract][Full Text] [Related]
17. PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1.
Ji J; Ding K; Luo T; Xu R; Zhang X; Huang B; Chen A; Zhang D; Miletic H; Bjerkvig R; Thorsen F; Wang J; Li X
Oncogene; 2020 Jan; 39(5):1125-1139. PubMed ID: 31605013
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitylation of Fe65 adaptor protein by neuronal precursor cell expressed developmentally down regulated 4-2 (Nedd4-2) via the WW domain interaction with Fe65.
Lee EJ; Hyun S; Chun J; Shin SH; Kang SS
Exp Mol Med; 2009 Aug; 41(8):555-68. PubMed ID: 19381069
[TBL] [Abstract][Full Text] [Related]
19. Nedd4 is a specific E3 ubiquitin ligase for the NMDA receptor subunit GluN2D.
Gautam V; Trinidad JC; Rimerman RA; Costa BM; Burlingame AL; Monaghan DT
Neuropharmacology; 2013 Nov; 74():96-107. PubMed ID: 23639431
[TBL] [Abstract][Full Text] [Related]
20. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
